These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 36812340)
1. An Adapted Self-screening Tool for Peripartum Cardiomyopathy in Haiti. Rene C; Faustin M; Bonhomme J; Deschamps MM; Jean-Gilles M; Rosenberg R; Ibrahim M; McNairy M; Pape JW; Devieux JG Crit Pathw Cardiol; 2023 Mar; 22(1):19-24. PubMed ID: 36812340 [TBL] [Abstract][Full Text] [Related]
3. A community-engaged approach to translate a Vaccine Hesitancy Scale into Haitian Creole. Sirek G; Ulysse S; Jacques Toussaint M; Nosamiefan C; Desrosiers L; Chandler M; Ramsey-Goldman R; Fleurissaint DJ; Feldman CH Vaccine; 2024 Apr; 42(9):2127-2134. PubMed ID: 38458871 [TBL] [Abstract][Full Text] [Related]
4. Worldwide Incidence of Peripartum Cardiomyopathy and Overall Maternal Mortality. Isogai T; Kamiya CA Int Heart J; 2019 May; 60(3):503-511. PubMed ID: 31019181 [TBL] [Abstract][Full Text] [Related]
5. Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Fett JD; Christie LG; Murphy JG Ann Intern Med; 2006 Jul; 145(1):30-4. PubMed ID: 16818926 [TBL] [Abstract][Full Text] [Related]
6. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Fett JD; Christie LG; Carraway RD; Murphy JG Mayo Clin Proc; 2005 Dec; 80(12):1602-6. PubMed ID: 16342653 [TBL] [Abstract][Full Text] [Related]
7. Incidence, Risk Factors, and Clinical Characteristics of Peripartum Cardiomyopathy in South Korea. Lee S; Cho GJ; Park GU; Kim LY; Lee TS; Kim DY; Choi SW; Youn JC; Han SW; Ryu KH; Na JO; Choi CU; Seo HS; Kim EJ Circ Heart Fail; 2018 Apr; 11(4):e004134. PubMed ID: 29626099 [TBL] [Abstract][Full Text] [Related]
8. Emerging insights into peripartum cardiomyopathy. Fett JD; Carraway RD; Perry H; Dowell DL J Health Popul Nutr; 2003 Mar; 21(1):1-7. PubMed ID: 12751668 [TBL] [Abstract][Full Text] [Related]
9. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Sliwa K; Hilfiker-Kleiner D; Mebazaa A; Petrie MC; Maggioni AP; Regitz-Zagrosek V; Schaufelberger M; Tavazzi L; van Veldhuisen DJ; Roos-Hesslink JW; Shah AJ; Seferovic PM; Elkayam U; van Spaendonck-Zwarts K; Bachelier-Walenta K; Mouquet F; Kraigher-Krainer E; Hall R; Ponikowski P; McMurray JJ; Pieske B Eur J Heart Fail; 2014 May; 16(5):583-91. PubMed ID: 24591060 [TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the newly translated creole multidimensional scale of perceived social support (MSPSS) and perceived adequacy of resource scale (PARS) and the relationship between perceived social support and resources in Haitian mothers in the US. Hannan J; Alce M; Astros A BMC Psychol; 2016 Feb; 4():7. PubMed ID: 26860220 [TBL] [Abstract][Full Text] [Related]
12. Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Fett JD; Fristoe KL; Welsh SN Int J Gynaecol Obstet; 2010 Apr; 109(1):34-6. PubMed ID: 19945699 [TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of pregnant women with cardiomyopathy stratified by etiologies: A population-based study. Phan D; Duan L; Ng A; Shen AY; Lee MS Int J Cardiol; 2020 Apr; 305():87-91. PubMed ID: 31889561 [TBL] [Abstract][Full Text] [Related]
14. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Warraich RS; Sliwa K; Damasceno A; Carraway R; Sundrom B; Arif G; Essop R; Ansari A; Fett J; Yacoub M Am Heart J; 2005 Aug; 150(2):263-9. PubMed ID: 16086928 [TBL] [Abstract][Full Text] [Related]
16. An update on treatments and outcomes in peripartum cardiomyopathy. Sheppard R; Rajagopalan N; Safirstein J; Briller J Future Cardiol; 2014 May; 10(3):435-47. PubMed ID: 24976479 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Bauersachs J; König T; van der Meer P; Petrie MC; Hilfiker-Kleiner D; Mbakwem A; Hamdan R; Jackson AM; Forsyth P; de Boer RA; Mueller C; Lyon AR; Lund LH; Piepoli MF; Heymans S; Chioncel O; Anker SD; Ponikowski P; Seferovic PM; Johnson MR; Mebazaa A; Sliwa K Eur J Heart Fail; 2019 Jul; 21(7):827-843. PubMed ID: 31243866 [TBL] [Abstract][Full Text] [Related]
18. Risk Prediction for Peripartum Cardiomyopathy in Delivering Mothers: A Validated Risk Model: PPCM Risk Prediction Model. Davis MB; Jarvie J; Gambahaya E; Lindenfeld J; Kao D J Card Fail; 2021 Feb; 27(2):159-167. PubMed ID: 33388467 [TBL] [Abstract][Full Text] [Related]
19. Post-COVID-19 Peripartum Cardiomyopathy: Experience from a Large Tertiary Referral Center. Yaniv-Salem S; Dym L; Nesher L; Zahger D; Shalev A; Shmueli H Isr Med Assoc J; 2023 Aug; 25(8):533-537. PubMed ID: 37574890 [TBL] [Abstract][Full Text] [Related]